METHOD DEVELOPMENT AND VALIDATION OF AMLODIPINE BESYLATE BY UV-VISIBLE SPECTROPHOTOMETRIC METHOD
DOI:
https://doi.org/10.71366/ijwos03072665696Keywords:
Amlodipine Besylate, API formulation, Quantitative and Qualitative Analysis
Abstract
Methods were reported for the estimation of n in amlodipine besylate dosage forms. UV spectroscopic study was reported for amlodipine besylate in a single dosage form. So the present study was aimed at the development of a simple, accurate, rapid, and economical UV spectrophotometric assay method for the determination of amlodipine besylate in bulk and tablet formulation. The solvent selected for stock solution preparation was water, and the required concentrations were prepared using the same solvent. The λmax for detection of amlodipine besylate was found to be 360nm. In this method, amlodipine besylate followed linearity in the concentration range of 1, 2, 3, 4, 5, 6, 7, 8, and 9 µg/mL with a regression coefficient (r²) of 0.999. The percent drug content was found to be 101.60057 ± 2.0815391 for amlodipine besylate API formulation. The method was found to be accurate and precise, as indicated by recovery studies, with recoveries close to 100% and RSD less than 2.
Inter-day precision: 0.1368
Intraday precision: 1.135
LOD: 0.387269 µg/mL LOQ:1.1735424µg/mL
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


